Phase 3 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have volunteered to take part and have signed a consent form agreeing to participate
- People who have had surgery to fully remove a tumour in the chest area of the oesophagus (food pipe), with lab tests confirming it was a type of cancer called squamous cell carcinoma
- People who did not receive any cancer treatments before their surgery
- People whose cancer, based on the 8th edition of a standard cancer staging system, has spread to nearby lymph nodes but not to distant parts of the body (specifically classified as pT1b-3N1-2M0) (confirm with trial site)
- People with a general health and activity level rated as 0 or 1 on the WHO performance scale, meaning they are fully active or have only minor limitations in physical activity
- People aged 18 to 75 years old, of any gender
- People whose heart, liver, and kidney test results from within one week before starting treatment meet the required health standards
Who may not be able to join:
- People whose surgery was performed using a left-sided chest surgical approach
- People who experienced serious complications after surgery that prevent them from receiving further treatment
- People who received other cancer treatments before joining the trial, or people who have another active cancer elsewhere in the body (with exceptions potentially made for certain non-melanoma skin cancers, cervical cancer that has not spread, or early prostate cancer that has been fully treated — confirm with trial site)
- People with blood clotting problems, a tendency to bleed (such as an active stomach or intestinal ulcer), or who are currently taking blood-thinning or clot-dissolving medications
- People with serious pre-existing heart conditions, including heart failure, difficult-to-control irregular heartbeats, unstable chest pain, a heart attack within the past six months, severe heart valve disease, or very hard-to-treat high blood pressure; or people with serious liver or kidney problems
- People with uncontrolled neurological or mental health conditions that would make it difficult to cooperate with the study or accurately report how they are feeling during treatment
- People with a known or suspected allergy to chemotherapy drugs used in this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chun Chen, MD, Fujian Medical University Union Hospital
Phone: +8659186218408
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall Survival; Overall Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.